23 results

• ISMP Warns of Errors Involving “Depo”-Style Injection Drugs

  April 11, 2016

  Irvin Jackson

  The ISMP warns of frequent medication errors between Depo-style injection drugs, such as Depo-Provera, Depo-Testosterone and Depo-Medrol which have resulted in adverse events for patients.

• Lawsuits Over Testosterone Generic Drugs Survive Pre-emption for Fraudulent Off-Label Marketing

  March 9, 2016

  Austin Kirk

  A federal judge has ruled that plaintiffs can continue to pursue off-label marketing claims against generic testosterone drug manufacturers, even though failure to warn claims are preempted.

• Generic Testosterone Drug Lawsuits Dismissed Based on Federal Preemption

  November 23, 2015

  Austin Kirk

  Heart attack and stroke lawsuits filed against the makers of generic testosterone drugs have been dismissed on preemption grounds, including claims against Depo-Testosterone and Testopel, which some plaintiffs argue are brand name drugs.

• Testosterone Therapy Heart Attack, Stroke Risk Among Healthy Men Questioned in New Study

  November 11, 2015

  Irvin Jackson

  The findings of a new study indicate no link between testosterone drugs and cardiovascular risks, adding to the conflicting number of studies over the safety of the popular men's medications.

• Many Continuing Medical Education Teachers Pushing Testosterone Treatment Paid by Manufacturers: Report

  October 23, 2015

  Irvin Jackson

  An investigative report has found that doctors paid by pharmaceutical companies are using educational courses to promote heavier use of testosterone drugs.

• Testosterone Medication Lawsuits Continue to Move Forward As Number of Cases Grow

  October 22, 2015

  Austin Kirk

  Testosterone manufacturers face more than 2,700 lawsuits over claims of heart attacks, strokes and sudden death in federal courts, and a judge has ordered AbbVie to provide clinical trial and safety information about other testosterone products to plainitiffs.

• Lawyers Reappointed to Leadership Roles in Testosterone Therapy MDL

  September 24, 2015

  Austin Kirk

  The U.S. District Judge presiding over the federal testosterone therapy litigation has re-appointed a group of plaintiffs' lawyers to continue serving in leadership roles in the MDL, as a number of cases are being prepared for early trial dates.

• Testosterone Heart Risks Evaluated Between Gels, Injections, Patches in Recent Study

  September 4, 2015

  Austin Kirk

  Some types of testosterone replacement therapy may put men more at risk of heart attack than others, according to the findings of a new study.

• Low Testosterone Drug Lawsuits Reach 2,000 in MDL

  July 20, 2015

  Austin Kirk

  A status conference will be held today before the U.S. District Judge presiding over nearly 2,000 testosterone drug lawsuits.

• High Testosterone Levels Increases Risk of Enlarged Prostate: Study

  May 21, 2015

  Irvin Jackson

  A new study finds that high levels of testosterone correlate with larger prostates, with researchers finding implications in the use of low-T drugs.